LANCASHIRE, UK. May 3rd 2024 – UV radiation poses a significant threat to our skin, with melanin pigments providing partial protection by absorbing and reflecting incoming radiation. Drawing inspiration from this natural defence, a UK company has developed SOLARAP™, an innovative material that mimics the skin's protective mechanism.
Thomas Hunt, CEO of TLX Insulation Ltd says “After two years of dedicated research and development our team have come up with a new concept in solar barrier material that we will be using to protect vaccines. Despite being just 0.5mm thick, SOLARAP™ nano-pores boast a remarkable surface area of 35.3 m2/g, equivalent to eight football pitches. These minute circular pores form an effective barrier to ultra-violet by scattering and absorbing incoming radiation.”
The research journey began in the UK but swiftly transitioned to outback Australia where real-life conditions proved essential for development.
Senior Scientist Alice Harrop explains, "Protecting medicines and vaccines from shock temperature increases is challenging due to the diverse spectrum of solar radiation. These waves vary in intensity and angle of attack, influenced by atmospheric conditions and the sun's position. SOLARAP™ adapts accordingly, working harder as temperatures rise."
ENDS
ENDS
- Share This Article
Got News You'd Like To Share With The World? Our Press Release Distribution Starts At Just £95
